Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing interim analysis timing for Bayesian adaptive commensurate designs.

Xiao Wu1, Yi Xu2, Bradley P Carlin3

  • 1Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

Statistics in Medicine
|December 5, 2019
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Robust CATE estimation using novel ensemble methods.

Journal of biopharmaceutical statistics·2026
Same author

Wildfire smoke PM<sub>2.5</sub> and mortality rate in the contiguous United States: A causal modeling study.

Science advances·2026
Same author

Group Sequential Trial Design Using Stepwise Monte Carlo for Increased Flexibility and Robustness.

Statistics in medicine·2025
Same author

Lewy body dementia promotion by air pollutants.

Science (New York, N.Y.)·2025
Same author

Adaptive mobility responses during Hurricanes Helene and Milton in 2024.

medRxiv : the preprint server for health sciences·2025
Same author

Penalized Bayesian methods for product ranking using both positive and negative references.

Journal of biopharmaceutical statistics·2025
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

Bayesian adaptive clinical trials improve drug development for rare diseases by efficiently using historical data. This novel design optimizes interim analysis timing, saving resources and ensuring ethical drug evaluation.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmacoeconomics

Background:

  • Drug development for rare diseases faces statistical hurdles due to small patient populations.
  • Bayesian adaptive designs offer enhanced statistical efficiency and cost reduction by integrating external evidence.

Purpose of the Study:

  • To introduce a novel Bayesian adaptive commensurate design for clinical trials.
  • To optimize interim analysis timing using a specific payoff function.

Main Methods:

  • The proposed design adaptively borrows from historical data.
  • A payoff function, considering sample savings and decision accuracy, optimizes interim analysis timing.
  • The Bayesian algorithm is calibrated for frequentist properties (Type I error, power) through simulation.
Keywords:
Bayesian adaptive designhistorical datainterim analysisrare diseasestopping rule

Related Experiment Videos

Main Results:

  • The approach demonstrates increased statistical efficiency in rare disease drug development.
  • Optimized interim analysis timing leads to potential resource savings and improved decision-making.
  • The method maintains acceptable long-run frequentist properties.

Conclusions:

  • The novel Bayesian adaptive commensurate design offers a statistically efficient and ethically sound approach for rare disease drug trials.
  • This method optimizes resource allocation and decision-making through adaptive borrowing and payoff-driven interim analyses.
  • An R package, optimIA, facilitates the implementation of this approach.